TOP POSTER Response Of Necrobiotic Xanthogranuloma To Venetoclax in the Setting of Chronic Lymphocytic Leukemia Complicated by IgG Lambda Monoclonal Gammopathy Jeremy Bray, MD, Jason C. Sluzevich, MD
TOP POSTER From the Medical Board of the National Psoriasis Foundation: Perioperative Management of Immunomodulatory Agents in Patients With Psoriasis and Psoriatic Arthritis Warren A James, MD and Angela L. Rosenberg, DO
TOP POSTER 3D Bioprinting: A Review and Potential Applications for Mohs Micrographic Surgery Anika Pulumati, BA, Yanci Algarin, BS, Sarah Kim, BS, Steven Latta, BS, Jeffrey Li, Keyvan Nouri, MD, MBA
TOP POSTER Assessing GPT-4’s Diagnostic Accuracy with Darker Skin Tones: Underperformance and Implications Luna Samman (BA)1*, Edgar Akuffo-Addo (MHA)2*, Leena Munawar (MD)3, Maya Akbik (BS)4, Nelly Kokikian (BS)5, Raquel Wescott (BS)6, Jashin J. Wu (MD)7
YouTube as a Source of Information for Self-Skin Examinations: An Analysis of Content and Quality Yanci A. Algarin, BS; Anika Pulumati, BA; Alex Reznik, BA; Dr. Robert J. Pariser, MD
Establishing an Association Between the Incidence of Mood Disorders in Patients Experiencing Anogenital Pruritus Alex Balfour, BS ; Akira McDaniels, BS; Christina Kraus, BS
Efficacy of Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 (TYK2) Inhibitor, in Scalp Psoriasis by Baseline Psoriasis Area and Severity Index (PASI) and Baseline Body Surface Area (BSA): A Subanalysis of the Phase 3 Clinical Trial Data Andrew Blauvelt, MD, Howard Sofen, MD, Jo Lambert, MD, Joseph F. Merola, MD, Mark Lebwohl, MD, Kim Hoyt, MS, Renata M. Kisa, MD, Subhashis Banerjee, MD, Thomas Scharnitz, MD, Jeffrey J. Crowley, MD
Netherton Syndrome: Considering the Rare in a Nonspecific Presentation Riley H. Brown; Summer V. Morrissette, MD; Sarah F. McClees, MD; Thy N. Huynh, MD
The Impact of Next-Generation Sequencing on Interobserver Agreement and Diagnostic Accuracy of Desmoplastic Melanocytic Neoplasms Alice Chen, BA, Natasha Sharma, MS, Pragi Patel, BS, Shantel Olivares, BA, Pedram Gerami, MD
Treated Primary Cutaneous Malignant Melanoma with Later Metastasis Found in Clinical Presentation of Left Axilla Lymphadenopathy: A Case Report Brigitte Cochran, OMS III1; Sara Eliseo, OMS IV1, Austin Vaughn, OMS III2; Enzo Ferrara, OMS III1; Tamryn Van Der Horn, OMS III1; Jamie Edwards, DO3
Deucravacitinib Efficacy in Palmoplantar and Fingernail Psoriasis by Baseline Psoriasis Area and Severity Index (PASI) and Baseline Body Surface Area (BSA) in the Phase 3 POETYK PSO-1 and PSO-2 Trials Boni Elewski, MD, Jo Lambert, MD, Joseph F. Merola, MD, Mark Lebwohl, MD, Kim Hoyt, MS, Renata M. Kisa, MD, Subhashis Banerjee, MD, Thomas Scharnitz, MD, Jennifer Cather, MD
Deucravacitinib, an Oral, Selective, Allosteric Tyrosine Kinase 2 Inhibitor, in Plaque Psoriasis: 3-Year Psoriasis Area and Severity Index (PASI) Outcomes in the Long-term Extension of the Phase 3 POETYK PSO-1 and PSO-2 Trials Linda Stein Gold, MD, Subhashis Banerjee, MD, Matthew J. Colombo, PhD, Renata M. Kisa, MD, Victoria Berger, PharmD, RPh, Kim Hoyt, MS, Jennifer Soung, MD, Tiago Torres, MD, Neal Bhatia, MD, Brad P. Glick, DO, Mark D. Kaufmann, MD
Genomic Profiling of Inflammatory Biomarkers in Human Skin Explores Transcriptomic Indicators of Acute Photodamage Following UVB Exposure Hunter Gray, BS,1 Lauren Moy, MD, FAAD,1 Ronald Moy MD, FAAD
Deucravacitinib, an Oral, Allosteric, Selective Tyrosine Kinase 2 Inhibitor, in Patients With Plaque Psoriasis Who Screened Positive for Psoriatic Arthritis in POETYK PSO-1/PSO-2: Effect on Joint Pain and Peripheral Joint Disease vs Placebo and Apremilast Joseph F. Merola, MD, Philip Mease, MD, April W. Armstrong, MD, Vibeke Strand, MD, Thomas Lehman, PharmD, Jiyoon C. Choi, PhD, Brandon Becker, PhD, Yichen Zhong, PhD, Matthew J. Colombo, PhD, Diamant Thaçi, MD, Androniki Bili, MD, Alice B. Gottlieb, MD
Psoriasis Association With Occupational Organic Dust Exposure: A Cross-Sectional Analysis of NHANES 2009-2012 Data Among US Adults Sara Osborne, BS, Olivia Kam, BA, Carolynne Vo, BS, Raquel Wescott, BS, Shivani Thacker, DO, Jashin Wu, MD
Addressing Disparities: A Cross-Sectional Analysis of Diversity in Merkel Cell Carcinoma Clinical Trials Anika Pulumati BA, Yanci Algarin, BS, Sarah Kim, BS, Keyvan Nouri, MD
Use of Systemic Therapies for Vulvar Lichen Sclerosus and Vulvovaginal Lichen Planus: A Survey Study of Dermatologists and Gynecologists Celeste Richardson BS, Alexa Kassels BS, Ashley Elsensohn MD MPH, Olushola Akinshemoyin Vaughn MD, Christina Kraus MD
Influence of Marital Status on Stage at Presentation and Disease-Specific Survival in Sebaceous Carcinoma Mitchell Taylor, BA; Sierra Thomas, BS; Megan Wackel, MS; Divya Sharma, MD; Erin X. Wei, MD
Associations Between Immune-Related Conditions and Lymphoid Disorders: An Analysis of the Diverse All of Us Research Program Hanna Terhaar BS, Evan Liu BS, Dr. Nahiba Yusuf, PhD, MPH
Central Centrifugal Cicatricial Alopecia: Retrospective Case-Control Study of 54 Patients Katherine L. Wang, BS; Thais P. Pincelli, MD; Dane J. Markham, BS; Launia J. White; Zhuo Li, MS; Olayemi Sokumbi, MD; Alison J. Bruce, MBChB
Progression to Pleomorphic Dermal Sarcoma Following Recurrence of Atypical Fibroxanthoma Raquel M. Wescott, BS, Vishal K. Shah, BS, MSL, Andrew R. Tomlinson, MD